slides · global inventory
Chart
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 78,138
Current window 57,871-57,900
Pages 2,605
Rows per page 30
Component
57,871-57,900 of 78,138
04
The chart uses a gradient arrow to emphasize the scale of 12.2M participants compared to other biobanks.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
11
The slide highlights the scale of the 23andMe database and its application across three business pillars.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
19
The chart highlights that health care only accounts for 10% of the risk of premature death, framing the opportunity for non-clinical interventions.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
20
The slide uses a gradient color scheme for the bars. The data is sourced from a 2019 survey of 1,046 customers.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
30
Includes a conceptual diagram of SNP comparison and a multi-level zoom-in Manhattan plot.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
32
The slide uses a grid of small-multiple charts to show genetic association data across 12 medical categories. A specific example for NAFLD is highlighted at the bottom.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
33
The slide uses a central diagram of the TSLP receptor complex connected to five regional association plots (LocusZoom-style plots).23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
34
The heatmap shows log(OR) values for three TSLP GWAS signals across various diseases.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
36
The slide uses a timeline-style layout to show drug development stages from Discovery to Phase 2.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
38
The slide uses a three-column process flow to connect market opportunity, genetic validation, and biological mechanism.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
40
The chart shows tumor growth inhibition over time, highlighting the triple combination (Anti-CD96 + Anti-TIGIT + Anti-PD1) as the most effective.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
61
Uses a 'fill in the blanks' analogy to explain genotype imputation.23andMe | Investor Presentation Deck | 63 slides · 23andMe
Pitch deck Investor relations 1 hit
44
The slide uses a donut chart to visualize revenue distribution across four sub-segments.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
51
The slide uses a donut chart to visualize the revenue composition of the Health Care business unit.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
53
The chart shows a clear shift from non-strategic segments to priority segments.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
54
The slide uses a three-column layout to detail strategic pillars, each with a numbered header, bulleted list, descriptive text, and visual evidence (photos or chart).3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
58
The slide uses a donut chart to visualize revenue distribution across six sub-segments.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
65
The slide highlights the segment's strategy of solving customer challenges through technology platform integration.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
79
The slide uses a bar chart to show cash flow performance and a list to explain the operational drivers.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
80
The slide highlights capital allocation strategy and debt management.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
85
The chart illustrates capital allocation strategy through shareholder returns.3M | Investor Day Presentation Deck | 94 slides · 3M
Conference presentation Investor relations Loop · Pattern Hunter1 hit
06
The slide uses a radial chart to show therapeutic area distribution and a nested donut/arc to show health focus (human vs animal).AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · NeedLoop · Golden Circle1 hit
07
The chart uses a stacked bar approach to show revenue components over time, with specific callouts for total values of research fees, clinical milestones, and royalties.AbCellera | Results Presentation Deck | 21 slides · AbCellera
Conference presentation Investor relations Beat · SatisfactionLoop · Golden Circle1 hit
30
The slide uses a bar chart to demonstrate operating leverage through margin expansion.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
31
The chart illustrates the bridge between the starting balance, realized gains, and value creation to reach the ending balance.TPG | Investor Presentation Deck | 38 slides · TPG
Pitch deck Investor relations 1 hit
11
The slide uses a standard pharmaceutical pipeline Gantt-style visualization.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · Solution1 hit
26
The slide uses a causal chain diagram to link genetic mutations to cellular outcomes, supported by empirical data from Kempthorne et al. 2020.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
28
PoM = Proof of Mechanism; ALSP = Adult-onset Leukoencephalopathy with Axonal Spheroids and Pigmented Glia.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank Beat · ProblemLoop · Cost Of Inaction1 hit
37
The chart shows dose-response curves for VG-2862 concentration vs. pSYK activation signal, comparing 'No Fab' (control) against four different Fabs.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit
46
The slide presents histological images and quantitative dot plots comparing Trem2 wild-type, heterozygous, and knockout mice.Vigil Neuroscience | IPO Presentation Deck | 54 slides · Vigil Neuroscience
Pitch deck Investment bank 1 hit